脑膜瘤中5-ALA动力学:肿瘤荧光与PpIX代谢的体外分析及与高级别胶质瘤的比较
本研究在两种永生化及原代WHO I/II级脑膜瘤细胞系和U87高级别胶质瘤细胞系中分析5-ALA(12.5-150 µg/ml)暴露后PpIX动力学,并检测FECH、ABCB6、ABCG2表达。结果显示Ben-Men 1和原代脑膜瘤荧光随5-ALA剂量增至100 µg/ml而升高后饱和,U87荧光仅轻微增加,IOMM-Lee无相关荧光;荧光与上述基因表达无关。
要点
- 脑膜瘤细胞系对5-ALA荧光适用性差异显著,Ben-Men 1和原代细胞呈剂量依赖。
- 5-ALA剂量增至100 µg/ml后脑膜瘤荧光饱和,150 µg/ml后下降更慢。
- 荧光强度与FECH、ABCB6、ABCG2表达及PpIX外排无关。
核心结论
- Ben-Men 1和原代脑膜瘤细胞荧光呈5-ALA剂量依赖,IOMM-Lee细胞无相关荧光,荧光与FECH、ABCB6、ABCG2表达无关。
研究设计与样本
- 体外研究,分析两种永生化及原代WHO I和II级脑膜瘤细胞系与U87高级别胶质瘤细胞系。
主要发现
- Ben-Men 1和原代WHO I/II级脑膜瘤荧光随5-ALA剂量升至100 µg/ml而增加后饱和,150 µg/ml后下降慢于100 µg/ml。
- U87细胞荧光随5-ALA剂量升高仅轻微增加。
- Ben-Men 1与原代脑膜瘤细胞在25-150 µg/ml 5-ALA后荧光动力学无差异(p > .05)。
- 原代I级与II级脑膜瘤在任何5-ALA剂量下荧光无差异(p > .05)。
- IOMM-Lee细胞未发现相关荧光,各细胞系FECH、ABCB6、ABCG2表达及PpIX外排不同但与荧光无关。
关键数值与推荐
- 5-ALA剂量范围12.5-150 µg/ml用于PpIX动力学分析。
- 荧光比较的5-ALA剂量点为25-150 µg/ml(Ben-Men 1与原代脑膜瘤,p > .05)。
- 原代I级与II级脑膜瘤荧光比较在任何5-ALA剂量下p > .05。
临床怎么用
- 体外结果支持在原位试验中进一步评估5-ALA荧光引导手术用于脑膜瘤,以回应目前讨论的不足。
局限性
- 研究为体外细胞系分析,未在临床手术中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Although the utility 5-aminolevulinic acid (5-ALA)-mediated fluorescence-guided surgery (FGS) in meningiomas is increasingly discussed, data about the kinetics of protoporphyrin IX (PpIX) and tumor fluorescence are sparse. METHODS: PpIX kinetics after exposition to varying 5-ALA doses (12.5-150 µg/ml) was analyzed in two immortalized as well as primary WHO grade I and II meningioma and U87 high-grade glioma cell lines. Expression of FECH, ABCB6 and ABCG2 was investigated by quantitative real-time PCR. RESULTS: Fluorescence in Ben-Men 1 and primary WHO grade I/II meningioma increased with rising 5-ALA doses up to 100 µg/ml but then showed a saturation effect. However, decrease of fluorescence was slower after 150 than after 100 µg/ml 5-ALA. Fluorescence in U87 cells marginally increased with rising 5-ALA doses. Kinetics of the fluorescence in Ben-Men 1 cells did not differ from primary meningioma cells after 25-150 µg/ml 5-ALA (p > .05, each). No difference was found when comparing the fluorescence between primary grade I and II meningiomas after any 5-ALA dosage (p > .05, each). No relevant fluorescence was found in IOMM-Lee cells. Expression of FECH, ABCB6 and ABCG2 as well as PpIX export differed between all analyzed cell lines but were not connected to fluorescence. CONCLUSIONS: Eligibility of established meningioma cell lines for in-vitro analyzes of tumor fluorescence significantly differs. Fluorescence in Ben-Men 1 and primary meningioma cell lines but less in IOMM Lee cells is 5-ALA dose-dependent, encouraging in-situ trials to encounter currently discussed shortcomings of FGS in meningiomas. Fluorescence is not related to expression of FECH, ABCB6 and ABCG2.
引用
- Bunk EC, Wagner A, Stummer W, et al. 5-ALA kinetics in meningiomas: analysis of tumor fluorescence and PpIX metabolism in vitro and comparative analyses with high-grade gliomas. J Neurooncol. 2021. PMID: 33389565. doi:10.1007/s11060-020-03680-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。